Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000992579 | SCV000520767 | likely benign | not provided | 2020-11-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30413633, 25646624) |
Athena Diagnostics | RCV000992579 | SCV001144980 | likely benign | not provided | 2018-12-07 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001002136 | SCV001159991 | uncertain significance | Polycystic kidney disease, adult type | 2019-03-15 | criteria provided, single submitter | clinical testing | The PKD1 c.4055G>A; p.Ser1352Asn variant (rs141274774) is reported in the literature in several individuals affected with autosomal dominant polycystic kidney disease, although its clinical significance was not conclusively determined (Eisenberger 2015, Rossetti 2007). This variant is found in the non-Finnish European population with an overall allele frequency of 0.13% (162/126792 alleles) in the Genome Aggregation Database. The serine at codon 1352 is moderately conserved and computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. However, due to limited information, the clinical significance of the p.Ser1352Asn variant is uncertain at this time. References: Eisenberger T et al. An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease. PLoS One. 2015 Feb 3;10(2):e0116680. Rossetti S et al. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2007 Jul;18(7):2143-60. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003987531 | SCV004804316 | likely benign | not specified | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001002136 | SCV005919513 | likely benign | Polycystic kidney disease, adult type | 2023-07-13 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000992579 | SCV002034877 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000992579 | SCV002036453 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003922750 | SCV004744623 | likely benign | PKD1-related disorder | 2023-12-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |